Recombinant human interleukin-18
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human interleukin-18, covering 2017-07-26 to 2017-07-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 [Phase 1]